Literature DB >> 2576286

Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I.

K Nakao1, N Ohba, M Matsumoto.   

Abstract

A consecutive series of 34 patients with HTLV-I-associated myelopathy (HAM), a neurological disease associated with human T-lymphotropic virus type I (HTLV-I), were studied with reference to endogenous ocular disorders. These patients were examined at the Kagoshima University Hospital between 1986 and 1988. Five of the 34 HAM patients showed noninfectious, granulomatous anterior uveitis responding to corticosteroid therapy and/or retinal microvascular changes such as isolated cotton-wool spots; one of the patients had recurrent uveitis. Additionally, twelve of 30 patients who had been infected with HTLV-I but remained healthy systemically had ocular manifestations similar to those in HAM patients were included in this study. The ocular lesions in these patients were not explained by any established disorders that manifest uveitis or retinal microangiopathy. Some of the HTLV-I-seropositive patients with ocular disorders showed antibodies against HTLV-I in the aqueous humor. This might have resulted from diffusion of serum antibodies through a damaged blood-aqueous barrier or local synthesis of antibodies. The HTLV-I infection might be primarily responsible for a certain form of endogenous anterior uveitis that has remained hitherto etiologically undefined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576286

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  20 in total

Review 1.  HTLV-I infection in human disease.

Authors:  D J Spalton; F Nicholson
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

3.  Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis.

Authors:  H Kawai; T Mitsui; K Yokoi; M Akaike; K Hirose; K Hizawa; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

4.  Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.

Authors:  M Ishioka; K Goto; S Nakamura; N Watanabe; E Uchio; K Saeki; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

5.  Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.

Authors:  B Poon; I S Chen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Clinical features of HTLV-I associated uveitis.

Authors:  K Nakao; N Ohba
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

7.  Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis.

Authors:  M Yamamoto; W Matsuyama; K Oonakahara; M Watanabe; I Higashimoto; M Kawabata; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

8.  Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.

Authors:  W Matsuyama; M Kawabata; A Mizoguchi; F Iwami; J Wakimoto; M Osame
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 9.  Human T lymphotropic virus type 1 uveitis.

Authors:  M Mochizuki; K Tajima; T Watanabe; K Yamaguchi
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

10.  HTLV-I associated uveitis in central Japan.

Authors:  K Goto; K Saeki; M Kurita; S Ohno
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.